Literature DB >> 2060544

Does tolerance develop to the sedative and amnesic effects of antidepressants? A comparison of amitriptyline, trazodone and placebo.

M Sakulsripong1, H V Curran, M Lader.   

Abstract

The psychomotor, sedative and memory effects of a sedative, anticholinergic antidepressant (amitriptyline), a sedative antidepressant (trazodone) and placebo were compared in a double-blind, cross-over study with 12 healthy volunteers. Amitriptyline (37.5 mg) and trazodone (100 mg) were administered for the first 7 days of treatment and in double-dosage for the next 7 days of treatment. Subjects completed a battery of tests before and 2 h after drug administration on days 1, 8 and 14. Over the 2 weeks of treatment, there was no accumulation of effects but subjects experienced marked sedation and psychomotor impairments following a daily dose of both active drugs. Although both amitriptyline and trazodone produced impairments on memory tasks, the effect of amitriptyline was significantly greater and may reflect its anticholinergic action over and above global sedative effects. Tolerance to the effects of amitriptyline built up differentially over measures of sedation, psychomotor function and memory.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060544     DOI: 10.1007/bf00315137

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  The SHP test--an aid in the detection and measurement of depression.

Authors:  R E PECK
Journal:  AMA Arch Gen Psychiatry       Date:  1959-07

Review 2.  Anticholinergic side-effects of antidepressants: studies of the inhibition of salivation.

Authors:  L Clemmesen
Journal:  Acta Psychiatr Scand Suppl       Date:  1988

3.  The cholinergic synapse and the site of memory.

Authors:  J A Deutsch
Journal:  Science       Date:  1971-11-19       Impact factor: 47.728

Review 4.  Interhemispheric differences in the localization of psychological processes in man.

Authors:  B Milner
Journal:  Br Med Bull       Date:  1971-09       Impact factor: 4.291

5.  Non-MAOI antidepressant drugs and cognitive functions: a review.

Authors:  P J Thompson; M R Trimble
Journal:  Psychol Med       Date:  1982-08       Impact factor: 7.723

6.  Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives.

Authors:  H V Curran; W Schiwy; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Models of cognitive impairment: cognitive changes in depression.

Authors:  H Weingartner; E Silberman
Journal:  Psychopharmacol Bull       Date:  1982-04

8.  Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles.

Authors:  H V Curran; M Sakulsriprong; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 9.  Tranquillising memories: a review of the effects of benzodiazepines on human memory.

Authors:  H V Curran
Journal:  Biol Psychol       Date:  1986-10       Impact factor: 3.251

  9 in total
  6 in total

Review 1.  A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.

Authors:  Cara Tannenbaum; Amélie Paquette; Sarah Hilmer; Jayna Holroyd-Leduc; Ryan Carnahan
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

Review 2.  Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidance.

Authors:  J G Ramaekers
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

3.  Memory and psychomotor effects of oxcarbazepine in healthy human volunteers.

Authors:  H V Curran; R Java
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Cognitive performance in depressed patients after chronic use of antidepressants.

Authors:  Clarice Gorenstein; Stefania Caldeira de Carvalho; Rinaldo Artes; Ricardo Alberto Moreno; Tania Marcourakis
Journal:  Psychopharmacology (Berl)       Date:  2006-02-17       Impact factor: 4.530

Review 5.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

Authors:  M Haria; A Fitton; D McTavish
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

6.  The effects of trazodone on human cognition: a systematic review.

Authors:  Ana Mafalda Gonçalves Gonçalo; Maria Augusta Vieira-Coelho
Journal:  Eur J Clin Pharmacol       Date:  2021-06-07       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.